If you have breast cancer that is ER+, PR-, and HER2+, your treatment plan may include a combination of targeted therapies, hormone therapies, and possibly chemotherapy. Here are some common treatments:

- Targeted Therapies: Drugs like trastuzumab (Herceptin) and pertuzumab (Perjeta) specifically target HER2-positive Show Full Answer

If you have breast cancer that is ER+, PR-, and HER2+, your treatment plan may include a combination of targeted therapies, hormone therapies, and possibly chemotherapy. Here are some common treatments:

- Targeted Therapies: Drugs like trastuzumab (Herceptin) and pertuzumab (Perjeta) specifically target HER2-positive cancer cells.
- Hormone Therapies: Medications such as tamoxifen and aromatase inhibitors may be used to block estrogen, which fuels ER+ cancer cells.
- Chemotherapy: Often combined with targeted therapies to improve effectiveness.

Effectiveness varies by individual, so it's important to follow your oncologist's recommendations and discuss any concerns with them.

 This AI-generated response comes from MyBCTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

6 HER2-Positive Breast Cancer Treatments: Chemotherapy and More | MyBCTeam

How Early-Stage HER2-Positive Breast Cancer Treatment Has Evolved | MyBCTeam